Epithalon vs Retinalamin

Overview

Epithalon and Retinalamin are both studied in the peptide research space.

Epithalon: A synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian scientist Vladimir Khavinson, claimed to activate telomerase and extend lifespan.

Retinalamin: A peptide complex extracted from bovine or porcine retinal tissue, developed by Russian scientist Vladimir Khavinson for ophthalmologic applications.

Evidence Comparison

Aspect	Epithalon	Retinalamin
Evidence Level	Low	Moderate
Human Studies	5	8
Preclinical Studies	15	8
Total Sources	28	18

Key Differences

Aspect	Epithalon	Retinalamin
Category	Longevity	Other
Evidence Strength	Low	Moderate
Total Sources	28	18
Human Studies	5	8

Summary

• Epithalon: Low evidence with 28 total sources (5 human)
• Retinalamin: Moderate evidence with 18 total sources (8 human)

---

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.